EUVIMEDEUVIMED entdecken
Crossref

Synthesis and Biological Evaluation of 1‐(4‐(Methylsulfonyl)Phenyl)‐5‐Phenyl‐1H‐Pyrazole‐4‐Carboxamides as Epidermal Growth Factor Receptor‐Targeting Anticancer Agents

Madhava Rao Bandaru, Muvvala Venkatanarayana iD, Vikram Basava, Sharath Babu Haridasyam

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202403418 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Madhava Rao Bandaru und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, GITAM School of Science, GITAM (Deemed to be) University, Hyderabad, India. Hauptthemen laut MEDLINE: ErbB Receptors, Antineoplastic Agents, Pyrazoles, Protein Kinase Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We reported the synthesis of novel pyrazole amide derivatives. The newly synthesized compounds are exhibiting in vitro anti‐cancer efficacy against MCF‐7 and A‐549 human cancer cell lines. The compounds, 6m , 6o , and 6p have greater activity against A‐549 cell lines with reference to 5‐Fluorouracil. Similarly, in vitro, epidermal growth factor receptor results revealed that compounds 6p (50% inhibitory concentration [IC 50 ] = 0.79 ± 0.04 µM) and 6m (IC 50 = 0.86 ± 0.06 µM) have shown improved activity in comparison to the standard Erlotinib (IC 50 = 0.41 ± 0.03 µM). This article systematically examines the docking studies of lead compounds 6i , 6m , 6o , and 6p , finally found compound 6o showing better binding properties (‐10.85 kcal) among all.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErbB ReceptorsAntineoplastic AgentsPyrazolesProtein Kinase InhibitorsAmidesHumansStructure-Activity RelationshipDrug Screening Assays, AntitumorMolecular Docking SimulationCell ProliferationMolecular StructureDose-Response Relationship, DrugCell Line, TumorMCF-7 Cells

Stichwörter der Autor:innen

EGFR‐targetingamide derivatives of pyrazoleanticancer agentsdocking studiesin vitro activity

Substanzen

ErbB ReceptorsAntineoplastic AgentsPyrazolesProtein Kinase InhibitorsAmidesEGFR protein, human

Autor:innen und Institutionen

  • Department of Chemistry, GITAM School of Science, GITAM (Deemed to be) University, Hyderabad, India.
  • Department of Chemistry, GITAM School of Science, GITAM (Deemed to be) University, Bangalore, India.

ORCID-Profile: Muvvala Venkatanarayana

Zitieren

APA

Bandaru, M. R., Venkatanarayana, M., Basava, V., & Haridasyam, S. B. (2025). Synthesis and Biological Evaluation of 1‐(4‐(Methylsulfonyl)Phenyl)‐5‐Phenyl‐1H‐Pyrazole‐4‐Carboxamides as Epidermal Growth Factor Receptor‐Targeting Anticancer Agents. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202403418

Vancouver

Bandaru MR, Venkatanarayana M, Basava V, Haridasyam SB. Synthesis and Biological Evaluation of 1‐(4‐(Methylsulfonyl)Phenyl)‐5‐Phenyl‐1H‐Pyrazole‐4‐Carboxamides as Epidermal Growth Factor Receptor‐Targeting Anticancer Agents. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202403418

BibTeX
@article{Bandaru2025,
  author = {Bandaru, Madhava Rao and Venkatanarayana, Muvvala and Basava, Vikram and Haridasyam, Sharath Babu},
  title = {Synthesis and Biological Evaluation of 1‐(4‐(Methylsulfonyl)Phenyl)‐5‐Phenyl‐1H‐Pyrazole‐4‐Carboxamides as Epidermal Growth Factor Receptor‐Targeting Anticancer Agents},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202403418}
}
Kostenlos starten →